IG-SRT VS Mohs

Image-Guided Superficial Radiotherapy is an ideal first-line non-melanoma skin cancer treatment option. IG-SRT delivers predictable, consistent results across all skin types and is FDA-cleared and recommended by the National Comprehensive Cancer Network.

For patients with squamous cell and basal cell carcinomas, IG-SRT has a better than 99% cure rate.

Don’t take our word for it, here’s what some of our Practice Partners have to say about IG-SRT with SkinCure Oncology:

“I really think every Mohs Surgeon should have this unit. It provides an alternative for the cases that are extreme. A Mohs surgeon is subject to whatever cases are sent their way and they have to essentially perform surgery on whatever is sent, for the most part. I can’t think of a reason why you would not want to have IG-SRT in your practice.” – Dr. Dina Hunter MD

“Many dermatologists that are full service do have Mohs surgeons, but a lot of times patients will come in and discuss with the Mohs surgeon whether the surgical option or non-surgical option is best. A lot of times the surgical option is what they choose but having a non-surgical option for patients is a great advantage to the patient and a great advantage to the practice.” – Dr. Marguerite Germain, MD